Scientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

This summer, UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s opposition to the merger.

Swiss National Bank grew its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the ...

UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger, after the Department of Justice moved to block the deal.

UnitedHealth and Amedisys have agreed to extend the deadline to close their $3.3 billion merger agreement to next year, a filing showed on Friday, as the deal faces close scrutiny from the U.S ...

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden ...

The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys. The government is citing concerns the deal would hinder access to home health and hospice services ...

Amedisys and UnitedHealth Group plan to divest care centers to an affiliate of VitalCaring Group. Several experts said this will likely clear the way for the companies' merger.

Amedisys, a large home health provider, plans to divest a number of care centers to an affiliate of VitalCaring Group in advance of its planned merger with UnitedHealth Group later this year ...